-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Oncoquest in Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Oncoquest in Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Oncoquest in Chronic Lymphocytic Leukemia (CLL) Drug Details: Oncoquest vaccine...
-
Sector Analysis
Ovarian Cancer Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Ovarian Cancer Market Report Overview The ovarian cancer market across the 7MM was valued at $3.3 billion in 2022. The market will grow at a CAGR of more than 1% from 2022 to 2032. The 7MM includes the US, France, Germany, Italy, Spain, the UK, and Japan. Ovarian cancer is one of the most lethal gynecological cancers worldwide. Approximately 90% of ovarian cancer cases are epithelial, with distinct sites of origin arising from the ovarian surface epithelium or distal fallopian...
-
Product Insights
NewTransitional Cell Carcinoma (Urothelial Cell Carcinoma) – Drugs In Development, 2024
Empower your strategies with our Transitional Cell Carcinoma (Urothelial Cell Carcinoma) – Drugs In Development, 2024 report and make more profitable business decisions. Transitional cell carcinoma (TCC), also known asurothelial cell carcinoma, is a type of cancer that primarily affects the transitional epithelial cells lining the urinary tract, including the bladder, ureters, and renal pelvis. It is the most common form of bladder cancer. TCC arises when these cells undergo malignant changes, often due to exposure to carcinogens like tobacco or...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Oregovomab in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Oregovomab in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Oregovomab in Endometrial Cancer Drug Details: Oregovomab is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zalifrelimab in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zalifrelimab in Cervical Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zalifrelimab in Cervical Cancer Drug Details: AGEN-1884 (zalifrelimab) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SH-748 in Nodal Marginal Zone B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SH-748 in Nodal Marginal Zone B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SH-748 in Nodal Marginal Zone B-Cell Lymphoma Drug Details:SH-748 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Oncoquest
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Oncoquest Drug Details Oncoquest vaccine is under development for the treatment of non-Hodgkin's follicular...
-
Product Insights
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ovarian Cancer Pipeline Drugs Market Overview Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, and changes in bowel habits, such as constipation, loss of appetite, and low back pain. The predisposing factors include age and family history. Treatment includes surgery, chemotherapy, and radiation therapy....
-
Product Insights
Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Prostate cancer usually occurs in older men. Its symptoms include problems while urinating, decreased force in the stream of urine, blood in the urine, pain in the lower back, hips, or thighs, bone pain, and erectile dysfunction. The Prostate Cancer pipeline market research report provides comprehensive information on the therapeutics under development for Prostate Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – oregovomab
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry oregovomab Drug Details Oregovomab is under development for the treatment of ovarian cancer, pancreatic...